-
Endo International Notifies Vivus It Will End Its Commercial Supply And License Agreements Related To Avanafil
Thursday, December 31, 2015 - 9:32am | 118Read More...Endo International plc (NASDAQ: ENDP) announced in an 8-K filing on Wednesday that it plans on terminating its commercial supply and license agreements with VIVUS, Inc. (NASDAQ: VVUS) related to its right to commercialize Avanafil. Endo International received exclusive rights to commercialize...
-
More Waves In Pharma: Endo Buys TPG Capital's Par Pharma for $8 Billion
Monday, May 18, 2015 - 8:58am | 258Read More...Endo International plc (NASDAQ: ENDP) will buy Par Pharmaceutical from TPG Capital for $1.5 billion in stock and $6.5 billion in cash, the companies announced. Endo was up more than 1 percent in pre-market trading on news of the deal, which will create one of the top five generic drug...
-
Dow Suffers Worst One-Day Performance In 2014, Volatility Returns To The Markets
Thursday, October 9, 2014 - 4:55pm | 2188Read More...U.S. stocks plunged with the Dow, shedding more than 300 points, suffering the worst single day performance of the year. Despite the 300-plus point loss, both the S&P 500 and Nasdaq saw higher losses on a percentage basis as the CBOE Volatility Index surged over 24 percent to 18.76....
-
Market Wrap For March 6: Investors Find Positives In Jobless Claims
Thursday, March 6, 2014 - 6:06pm | 2478Read More...U.S. stocks rose as investors digested jobless claims data which fell to a three month low ahead of Friday's monthly employment report. The S&P 500 was lifted to a new all time high of 1,8881.94 while the Dow recorded modest gains. The Nasdaq finished in the red The Fed's Bill Dudley...
